Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Gb, Mcdonald"'
Autor:
PJ Martin, BJ Nelson, FR Appelbaum, C Anasetti, HJ Deeg, JA Hansen, GB McDonald, RA Nash, KM Sullivan, RP Witherspoon, PJ Scannon, N Friedmann, R Storb
Publikováno v:
Blood. 88:824-830
Acute graft-versus-host disease (GVHD) is most often treated with high dose glucocorticoids, but less than half of patients have durable overall improvement. Previous phase I and phase II studies suggested that treatment with a CD5-specific immunotox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e727e91e160b5e3bf38abd25691dd9a
https://doi.org/10.1182/blood.v88.3.824.bloodjournal883824
https://doi.org/10.1182/blood.v88.3.824.bloodjournal883824
Publikováno v:
Blood. 77:1821-1828
We have reviewed results of secondary therapy in 427 patients with acute graft-versus-host disease (GVHD) who did not have a durable satisfactory response after primary treatment. At the beginning of secondary treatment, 320 patients (75%) had rash,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::871ca5752dff718fc5a207202faa1a7c
https://doi.org/10.1182/blood.v77.8.1821.bloodjournal7781821
https://doi.org/10.1182/blood.v77.8.1821.bloodjournal7781821
Autor:
PJ Martin, G Schoch, L Fisher, V Byers, C Anasetti, FR Appelbaum, PG Beatty, K Doney, GB McDonald, JE Sanders
Publikováno v:
Blood. 76:1464-1472
We have reviewed results of therapy in 740 patients with grades II-IV acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation. At the beginning of therapy, 597 patients (81%) had rash, 369 (50%) had liver dysfunction and 396 (5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf51cea1b4e32f6505699027e971447a
https://doi.org/10.1182/blood.v76.8.1464.bloodjournal7681464
https://doi.org/10.1182/blood.v76.8.1464.bloodjournal7681464
Autor:
Hp, Kiem, Gb, Mcdonald, David Myerson, Cl, Spurgeon, Hj, Deeg, Je, Sanders, Doney K, Fr, Appelbaum, Km, Sullivan, Rp, Witherspoon, Storb R
Publikováno v:
Europe PubMed Central
Between 1971 and 1989 we have treated 19 patients with hepatitis-associated aplastic anemia by marrow transplantation from their HLA-identical siblings following conditioning with 200 mg/kg cyclophosphamide (Cy) administered over a period of 4 days.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::097d2eec0c93976cea72f7cf51432140
https://pubmed.ncbi.nlm.nih.gov/9118304
https://pubmed.ncbi.nlm.nih.gov/9118304
Publikováno v:
Europe PubMed Central
In March 1992, 12 bone marrow transplant patients at the Fred Hutchinson Cancer Research Center received blood components from donors who were anti-HCV-nonreactive by first generation ELISA but whose serum later tested anti-HCV-reactive to a second g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9568b83b525c0f03fc003049c3abf4d9
https://pubmed.ncbi.nlm.nih.gov/8722362
https://pubmed.ncbi.nlm.nih.gov/8722362
Autor:
Rc, Hackman, Jl, Wolford, Ca, Gleaves, David Myerson, Md, Beauchamp, Jd, Meyers, Gb, Mcdonald
Publikováno v:
Europe PubMed Central
This is a retrospective study of 54 consecutive upper gastrointestinal endoscopies in marrow graft recipients performed to determine the incidence and distribution of CMV infection in symptomatic patients and to compare the sensitivities of 7 CMV det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b27b5bce7ff29c607e138a7b73ec0cc6
https://pubmed.ncbi.nlm.nih.gov/8310514
https://pubmed.ncbi.nlm.nih.gov/8310514
Autor:
RA Clift, JA Bianco, FR Appelbaum, CD Buckner, JW Singer, L Bakke, WI Bensinger, RA Bowden, GB McDonald, M Schubert
Publikováno v:
Blood. 82(7)
This study evaluated the effect of pentoxifylline (PTX) on the incidence of regimen-related toxicity in patients receiving allogeneic marrow transplants from related donors. All patients received a regimen of methotrexate and cyclosporine as prophyla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8370abde700078ba961df87c4e246867
https://pubmed.ncbi.nlm.nih.gov/8400255
https://pubmed.ncbi.nlm.nih.gov/8400255
Publikováno v:
Blood. 80(10)
Seven patients were treated with recombinant human tissue plasminogen activator (tPA) for severe hepatic venocclusive disease (VOD) that developed after bone marrow transplantation for hematologic malignancy. Recombinant human tPA (10 mg/d x 2 days)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a90a48bc9bfb54770df8a1aed4772f8
https://pubmed.ncbi.nlm.nih.gov/1421368
https://pubmed.ncbi.nlm.nih.gov/1421368
Publikováno v:
Blood. 83:2383-2383
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27b9fc3416378fbc8888cb489a438ec7
https://doi.org/10.1182/blood.v83.8.2383a.bloodjournal8382383a
https://doi.org/10.1182/blood.v83.8.2383a.bloodjournal8382383a
Autor:
KM Sullivan, HM Shulman, R Storb, PL Weiden, RP Witherspoon, GB McDonald, MM Schubert, K Atkinson, ED Thomas
Publikováno v:
Blood. 57(2)
Fifty-two of 175 (30%) survivors of allogeneic marrow transplantation developed chronic graft-versus-hose diseases (GVHD). Five with limited chronic GVHD had an indolent clinical course with involvement of only the skin and liver. Forty-seven with ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b70cddc90232f7466655426f9c2d3130
https://pubmed.ncbi.nlm.nih.gov/7004534
https://pubmed.ncbi.nlm.nih.gov/7004534